How Chlamydia proteins hijack a cell's internal skeleton
Chlamydia type III effectors affecting the host actin-based cytoskeleton
Researchers explore how two proteins from the Chlamydia bacteria change the internal framework of infected cells in ways that help the infection grow.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Kentucky NIH-funded |
| Lab location | 1 site (Lexington, United States) |
| Project ID | NIH-11262329 on NIH RePORTER |
What this research studies
Scientists will use human cell cultures and related mouse models to study two Chlamydia effectors called TmeA and TmeB and how they alter the actin cytoskeleton inside infected cells. They will make mutant bacteria missing these proteins and use microscopy and biochemical tests to track how cellular resources are redirected to the bacterial compartment. The team will map how these changes help the bacteria develop and avoid built-in cell defenses. Learning these steps could point to targets for future drugs or vaccines to prevent tissue damage from infection.
Who could benefit from this research
Good fit: People with current, recurrent, or high-risk Chlamydia trachomatis infection would be the eventual beneficiaries and potential candidates for follow-up clinical research.
Not a fit: Patients seeking immediate medical treatment for an active infection are unlikely to receive direct benefit from this laboratory-focused work.
Why it matters
Potential benefit: If successful, this work could reveal new targets for treatments or vaccines to prevent or limit Chlamydia infections.
How similar studies have performed: Prior lab and animal-model research has shown that targeting bacterial secretion systems can reduce infection, but the specific roles of TmeA and TmeB are newly characterized.
Where this research is happening
Lexington, United States
- University of Kentucky — Lexington, United States (Active)
Researchers
- Principal investigator: Fields, Kenneth a — University of Kentucky
- Study coordinator: Fields, Kenneth a
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.